MEDLIB-L Archives

June 2018, Week 1

MEDLIB-L@LIST.UVM.EDU

Options: Use Monospaced Font
Show HTML Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
"Kovac, Melissa A" <[log in to unmask]>
Reply To:
Kovac, Melissa A
Date:
Mon, 4 Jun 2018 14:21:01 +0000
Content-Type:
text/plain
Parts/Attachments:
text/plain (38 lines)
Received, thank you!

Melissa

From: Kovac, Melissa A
Sent: Friday, June 01, 2018 4:24 PM
To: [log in to unmask] <[log in to unmask]>
Subject: ILL: Gut 2018 epub May 5

Hi, everyone,

I requested the following article on Docline more than a week ago, and for various reasons it hasn't been filled. I'd like to provide it to my patron as soon as possible, so if anyone can fill the request, I would really appreciate it. I will be happy to route it through Docline and can pay up to $15.

Luthra P, Burr NE, Brenner DM, Ford AC. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and network meta-analysis . Gut. 2018 May 5. pii: gutjnl-2018-316001. doi: 10.1136/gutjnl-2018-316001. [Epub ahead of print]



Many thanks,

Melissa Kovac, MA, MLIS, AHIP
Medical Librarian
Porter Adventist Hospital
Harley E. Rice Medical Library
303-778-5859
[log in to unmask]<mailto:[log in to unmask]>
[log in to unmask]<mailto:[log in to unmask]>

(If an article is attached to this message, it is likely to be protected by Copyright Law (Title 17 U.S. Code) and distributing multiple copies or posting electronically requires permission of the copyright holder. As of 2011, Centura holds an annual corporate license with the Copyright Clearance Center which covers many journals. If you'd like to check coverage for your article, go to http://www.copyright.com/search.do?operation=show&page=annual)

*****************************************************************************
This communication is for the use of the intended recipient only.  It may 
contain information that is privileged and confidential.  If you are not the 
intended recipient of this communication, any disclosure, copying, further 
distribution or use thereof is prohibited.  If you have received this 
communication in error, please advise me by return e-mail or by telephone and 
delete/destroy it.
*****************************************************************************

ATOM RSS1 RSS2